Large-scale testing (Phase 3)Study completedNCT05704725
What this trial is testing
Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)
Who this might be right for
Chorioretinal Vascular Disease
Amgen 49